Silver Book Fact

Initiating and continuing beta-blocker use in most first-time heart attack survivors for 20 years would result in 72,000 fewer coronary heart disease deaths, 62,000 fewer heart attacks, and 447,000 gained life-years. Additionally, it would save up to $18 million.

Phiillips K, Shlipak M, Coxon P, Heidenreich P, et al. Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction. JAMA. 2000; 284(21): 2748-54. http://jama.ama-assn.org/cgi/content/abstract/284/21/2748

Reference

Title
Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction
Publication
JAMA
Publication Date
2000
Authors
Phiillips K, Shlipak M, Coxon P, Heidenreich P, et al.
Volume & Issue
Volume 284, Issue 21
Pages
2748-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Cardiovascular disease mortality has declined by over 50% since 1950, contributing more than any other factor to the increase of life expectancy during the past few decades.  
  • Between 1984 and 1998, the cost of treating heart attack patients rose $10,000. However, medical technology increased the life expectancy of heart attack patients by an average of 1 year-a…  
  • Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.  
  • Aspirin use in AFib patients
    Meta-analysis of a number of randomized controlled trials found that aspirin use in atrial fibrillation patients reduced stroke risk by an average 22%.  
  • There are currently 312 medicines in development for heart disease and stroke.